Results 81 to 90 of about 12,523 (206)
This study highlights the antifungal potential of 2‐mercaptobenzothiazole (MBT) and sulfonamides against multidrug‐resistant Candida albicans. In vitro assays and molecular docking with lanosterol 14α‐demethylase (L14αDM) reveal favorable activity and binding, supporting their repositioning as promising antifungal candidates. ABSTRACT Fungal infections
Bruno A. de Oliveira +6 more
wiley +1 more source
ABSTRACT Background Managing febrile neutropenia is challenging due to the limited sensitivity of blood culture (BC) and the lack of tools differentiating infectious from non‐infectious fever. T2 magnetic resonance (T2MR) is a culture‐independent system detecting bacteria (T2Bacteria) and yeasts (T2Candida); SeptiCyte RAPID is a host response assay ...
Anna Maria Peri +6 more
wiley +1 more source
Candida Drug Resistance in Patients With Diabetic Foot Ulcers: A Systematic Review and Meta‐Analysis
ABSTRACT Diabetic foot ulcers (DFUs) are one of the most serious and common complications that, if not treated properly, can lead to potential damage and even amputation. The aim of this systematic review and meta‐analysis was to assess the drug‐resistant Candida species in DFU.
Mohammad Hossein Ekvan +7 more
wiley +1 more source
Echinocandin termelő törzs molekuláris genetikai törzsfejlesztése
A dolgozatban bemutatásra kerül egy ipari és orvosi jelentőségű fonalas gomba, és annak iparilag releváns megközelítése. Továbbá ismertetésre kerül számos ipari technológia, mely segítségével a fonalas gomba hatóanyag termelése optimalizálható ...
Bodnár, Veronika
core
Cryptic Production of trans -3-Hydroxyproline in Echinocandin B Biosynthesis
Echinocandins are antifungal nonribosomal hexapeptides produced by fungi. Two of the amino acids are hydroxy- l -prolines: trans -4-hydroxy- l -proline and, in most echinocandin ...
Stefanie Houwaart +5 more
core +1 more source
Candida auris is a multidrug-resistant yeast pathogen causing outbreaks in health care facilities worldwide, and the emergence of echinocandin-resistant C. auris is a concern.
Banavali, Nilesh K +5 more
core +1 more source
The frequency of breakthrough invasive fungal diseases (IFDs) during echinocandin therapy is unclear. We retrospectively analyzed 534 hematologic patients treated with echinocandin (caspofungin, N = 55; micafungin, N = 306; anidulafungin, N = 173).
Khong, Pek Lan +11 more
core +1 more source
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
We studied three clinical isolates of Candida spp. (one C. tropicalis isolate and two C. glabrata isolates) from patients with invasive candidiasis.
David S. Perlin +2 more
core
Periodic surveillance of antifungal susceptibility among Aspergillus isolates is essential to guide effective treatment. This multicenter study analyzed 550 clinical Aspergillus isolates collected in Taiwan from 2021 to 2023, primarily from the ...
Ming-I Hsieh +4 more
doaj +1 more source
Pyrosequencing was compared to Sanger dideoxy sequencing to detect mutations in FKS1 responsible for reduced echinocandin susceptibility in Candida albicans.
Perlin, David S. +4 more
core +1 more source

